Invivyd, Inc. (IVVD)
0.986
+0.02
(+2.23%)
USD |
NASDAQ |
Aug 31, 09:54
Invivyd 1 Year Total Returns (Daily) : -2.58% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | -2.58% |
| August 27, 2026 | 3.34% |
| August 26, 2026 | -12.46% |
| August 25, 2026 | 67.71% |
| August 24, 2026 | 81.22% |
| August 21, 2026 | 88.77% |
| August 20, 2026 | 50.02% |
| August 19, 2026 | 68.04% |
| August 18, 2026 | 49.39% |
| August 17, 2026 | 4.72% |
| August 14, 2026 | -9.81% |
| August 13, 2026 | -13.53% |
| August 12, 2026 | -6.19% |
| August 11, 2026 | -10.69% |
| August 10, 2026 | -15.64% |
| August 07, 2026 | -1.80% |
| August 06, 2026 | -8.09% |
| August 05, 2026 | -16.53% |
| August 04, 2026 | -21.26% |
| August 03, 2026 | -24.68% |
| July 31, 2026 | -22.91% |
| July 30, 2026 | -22.65% |
| July 29, 2026 | -32.67% |
| July 28, 2026 | -29.14% |
| July 27, 2026 | -22.31% |
| Date | Value |
|---|---|
| July 24, 2026 | -24.52% |
| July 23, 2026 | -23.85% |
| July 22, 2026 | -18.41% |
| July 21, 2026 | -11.47% |
| July 20, 2026 | -8.32% |
| July 17, 2026 | 2.88% |
| July 16, 2026 | 14.70% |
| July 15, 2026 | 19.71% |
| July 14, 2026 | 10.20% |
| July 13, 2026 | 6.64% |
| July 10, 2026 | 5.10% |
| July 09, 2026 | 7.16% |
| July 08, 2026 | 15.18% |
| July 07, 2026 | 33.85% |
| July 06, 2026 | 13.45% |
| July 02, 2026 | 23.62% |
| July 01, 2026 | 18.47% |
| June 30, 2026 | 22.01% |
| June 29, 2026 | 29.90% |
| June 26, 2026 | 11.62% |
| June 25, 2026 | 24.78% |
| June 24, 2026 | 24.51% |
| June 23, 2026 | 33.29% |
| June 22, 2026 | 22.59% |
| June 18, 2026 | 29.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 80.24% |
| Amgen, Inc. | 55.58% |
| Anika Therapeutics, Inc. | 128.6% |
| BioCryst Pharmaceuticals, Inc. | 15.94% |
| Imunon, Inc. | -73.47% |